MUMBAI, India, April 4 -- Intellectual Property India has published a patent application (202537017174 A) filed by Lupin Inc., Baltimore, U.S.A., on Feb. 27, for 'drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof.'
Inventor(s) include Gupta, Vinita; Holl, Richard; Garegnani, James; and Kaufman, Gregory.
The application for the patent was published on April 4, under issue no. 14/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to a drug delivery system for contraception including a steroidal estrogenic compound, a steroidal progestogenic compound or a combination thereof for the purposes of contraception in a subject, and provides for an ultra-low ...